Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05087927 · ClinicalTrials.gov registry record
Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women
A clinical trial of HIV Prevention, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 31
- Enrollment target
- 1
- Study location
NCT05087927: Completed study of HIV Prevention, sponsored by University of North Carolina, Chapel Hill.
NCT05087927 is a study of HIV Prevention that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 31 participants, below the 381-participant average among 32 other HIV Prevention trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05087927, a study of HIV Prevention, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work with community members to develop and design the delivery of a program to promote awareness of and access to pre-exposure prophylaxis (PrEP) for HIV prevention among women living in public housing. Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC. Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.
Primary Outcome
A subset of the Attitudes toward PrEP Scale (APS) will be used to assess the association between message exposure and attitudes toward pre-exposure prophylaxis (PrEP). This sub-set scale will include nine items rated on a 5-point Likert scale (responses ranging from 1=Strongly Disagree to 5=Strongly Agree). The nine items are a sub-set of the original APS scale and will include four items comprising sub-scale 2, three items comprising sub-scale 3, and two items from sub-scale 1. A mean score wil
Conditions Studied
Interventions
- BEHAVIORAL Gain framing plus demographically targeted photos
- BEHAVIORAL Loss framing plus demographically targeted photos
- BEHAVIORAL Gain framing plus not demographically targeted photos
- BEHAVIORAL Loss framing plus not demographically targeted photos
Study Locations (1)
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2024-03-10 |
What the finished NCT05087927 record still lists
NCT05087927 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 381-participant average among 32 other HIV Prevention trials with a reported enrollment target (92% lower).
The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 4 interventions - of which Gain framing plus demographically targeted photos is the first listed.
NCT05087927 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05087927 about?
NCT05087927 is a clinical study titled "Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women". Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work wit...
What is the current status of trial NCT05087927?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2023-04-18. Estimated completion is 2024-03-10.
What conditions does trial NCT05087927 study?
This clinical trial studies the following conditions: HIV Prevention.
What interventions are being tested in trial NCT05087927?
The interventions under investigation include: Gain framing plus demographically targeted photos (BEHAVIORAL), Loss framing plus demographically targeted photos (BEHAVIORAL), Gain framing plus not demographically targeted photos (BEHAVIORAL), Loss framing plus not demographically targeted photos (BEHAVIORAL).
Who is sponsoring clinical trial NCT05087927?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05087927 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05087927's enrollment target sits among peer trials
31 29th of 32 higher than 4 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
RECRUITING · Phase 1
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI